Navigation Links
New Study Confers All Clear Status On Letrozole, Infertility Drug

Concerns about increased risk of birth defects associated with letrozole, a cost effective and an easy to use drug, commonly given for infertility treatment has been settled//. A new research has now established that the rate of birth defects associated with letrozole is very similar to that associated with clomiphene citrate, the first line treatment for infertility for more than 40 years that is associated with a low risk.

The researchers examined nearly 911 newborns who were treated for infertility with either clomiphene citrate or letrozole between 2001 and 2005.Babies of mothers treated with letrozole and clomiphene citrate had the same rate of incidence of birth defects.

The results of this study, which contradicts earlier studies linking letrozole to increased rates of inherited malformations, appear in the online version of Fertility and Sterility.

The drug letrozole has been increasingly used in infertility treatment in the recent years. No statistically significant difference in the incidence of minor/major birth defects or other chromosome abnormalities in newborns has been documented by the study. This highlights that letrozole can indeed be used in infertility treatment without increased birth defect risk to the fetus.

The reports of increased birth defects associated with use of the drug in earlier studies could be due to fault in the methodology. The previous studies compared the incidence of birth defects in children conceived through fertility treatments using letrozole and spontaneously conceived children. This equates to an oranges- and-apples comparison, as natural conception is always associated with a low risk of birth defects. In addition, previous studies had not taken care to include age-matched control and treatment groups.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating clubfoot ... over 100,000 children in their treatment program. Clubfoot is a pervasive problem in ... treatment is limited or non-existent. Without intervention, these children are destined to grow ...
(Date:7/24/2017)... Falls Church, VA (PRWEB) , ... July 24, ... ... is figuring out how to change manufacturers future. , The agency is hammering ... Century Cures Act, one of the farthest-ranging laws ever to affect FDA-regulated firms. ...
(Date:7/24/2017)... ... ... “The Perfect Gift”: a customizable and interactive Bible study guide for children. “The Perfect Gift” ... She has always accepted Christ as her Savior, yet never studied His word, surrendered ... when she wrote this book to her children, so they would know the importance of ...
(Date:7/24/2017)... ... July 24, 2017 , ... “Journey to the Light: ... novel that details a young woman’s path to finding herself. “Journey to the ... of published author, Jamie Grayson, an experienced writer of newsletters, manuals, and articles, who ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... of education and training standards for healthcare treatment providers, offers healthcare professionals ... the iaedp™ Core Curriculum. , Presented as either online or as a ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... N.C. , July 10, 2017 Locus ... Convertible Note to support the development of CRISPR-Cas3 antimicrobial ... Holdings Limited, a leading Chinese Internet services provider, and ... will advance multiple infectious disease product programs targeting antibiotic ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: